Electromed, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
Electromed, Inc. (ELMD) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of -$641.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-08-25
- Electromed, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2023-03-31 was $176.00K, a 700.00% increase year-over-year.
- Electromed, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2022-12-31 was $1.00K, a 0.00% change year-over-year.
- Electromed, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2022-09-30 was $44.00K, a 120.00% increase year-over-year.
- Electromed, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2022-03-31 was $22.00K, a 40.54% decline year-over-year.
- Electromed, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2026 was -$641.00K.
- Electromed, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was -$1.02M.
- Electromed, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was -$82.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 3 month as first filed | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 9 month as first filed | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$641.00K 10-K · filed 2026-08-25 | |||||
| 2025-06-30 | -$1.02M 10-K · filed 2026-08-25 | |||||
| 2024-06-30 | -$82.00K 10-K · filed 2025-08-26 | |||||
| 2023-03-31 | $176.00K 10-Q · filed 2023-05-09 | $177.00K derived: sum of 2 quarters · filed 2023-05-09 | $219.00K 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $1.00K 10-Q · filed 2023-02-14 | $43.00K 10-Q · filed 2023-02-14 | ||||
| 2022-09-30 | $44.00K 10-Q · filed 2023-11-07 | |||||
| 2022-03-31 | $22.00K 10-Q · filed 2023-05-09 | $23.00K derived: sum of 2 quarters · filed 2023-05-09 | $43.00K 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $1.00K 10-Q · filed 2023-02-14 | $21.00K 10-Q · filed 2023-02-14 | ||||
| 2021-09-30 | $20.00K 10-Q · filed 2022-11-08 | |||||
| 2021-03-31 | $37.00K 10-Q · filed 2022-05-10 | $44.00K derived: sum of 2 quarters · filed 2022-05-10 | $32.00K 10-Q · filed 2022-05-10 | -$32.00K 10-Q · filed 2021-05-11 | ||
| 2020-12-31 | $7.00K 10-Q · filed 2022-02-08 | -$7.00K 10-Q · filed 2021-02-09 | $32.00K 10-Q · filed 2021-02-09 | |||
| 2020-09-30 | -$39.00K 10-Q · filed 2020-11-10 | |||||
| 2020-03-31 | $30.00K 10-Q · filed 2020-05-12 | -$13.00K 10-Q · filed 2021-05-11 | $30.00K 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | $126.00K 10-Q · filed 2020-02-11 | $9.00K 10-Q · filed 2020-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |